Home/Filings/4/0001104659-24-002652
4//SEC Filing

Carey Thomas D. 4

Accession 0001104659-24-002652

CIK 0001162194other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 6:05 PM ET

Size

8.9 KB

Accession

0001104659-24-002652

Insider Transaction Report

Form 4
Period: 2024-01-05
Transactions
  • Award

    Stock Option (Right to buy)

    2024-01-05+205,794205,794 total
    Exercise: $2.47Exp: 2033-06-07Common Stock (205,794 underlying)
  • Award

    Common Stock

    2024-01-05+79,41279,412 total
Footnotes (4)
  • [F1]Represents Restricted Stock Units ("RSUs") that vest in four equal annual installments beginning January 5, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
  • [F2]25% of the shares underlying the option vest on June 8, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is fully vested, subject to the Reporting Person's continued service through the applicable vesting date.
  • [F3]Pursuant to the Agreement and Plan of Merger, dated October 4, 2023, by and among Standard BioTools Inc. (the "Company"), Martis Merger Sub, Inc. and SomaLogic, Inc. ("Soma Logic") (the "Merger"), each option to purchase SomaLogic common stock (a "SomaLogic Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the "Effective Time"), was converted into an option to acquire the number of shares of common stock of the Company equal to the product of (i) the number of shares subject to such SomaLogic Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 (the "Exchange Ratio") rounded down to the nearest whole number of shares of the Company's common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the SomaLogic Option by the Exchange Ratio, rounded up to the nearest whole cent.
  • [F4]Except as noted above, each assumed SomaLogic Option will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such SomaLogic Option immediately prior to the Effective Time.

Issuer

STANDARD BIOTOOLS INC.

CIK 0001162194

Entity typeother

Related Parties

1
  • filerCIK 0001574633

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:05 PM ET
Size
8.9 KB